Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ashley Shepard"'
Autor:
Ashley Shepard, David Diamond, Laura Willard, Jennifer Staples, Kirshjah Martin, Nicole Witherspoon
Publikováno v:
American Journal of Qualitative Research. 6:189-211
This study explored how discovering misattributed paternity in adulthood after commercial DNA testing impacts psychological well-being and identity formation. Thirty-three subjects participated in this phenomenological qualitative study. Eighteen had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0434bdb4aa18e0f7004bb01d7edfd669
https://doi.org/10.29333/ajqr/12611
https://doi.org/10.29333/ajqr/12611
Publikováno v:
Open Forum Infectious Diseases. 9
Background Administration of the oral carbapenem, tebipenem along with its broad spectrum of activity against anaerobic, Gram-positive and Gram-negative pathogens including extended-spectrum β-lactamase-producing Enterobacterales, offers clinicians
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09e4473ec8abbd11a63ec975869fb2d1
https://doi.org/10.1093/ofid/ofac492.678
https://doi.org/10.1093/ofid/ofac492.678
Autor:
Ashley Shepard, James Nugent, Marguerite L. Monogue, Arlinda Baummer-Carr, David P. Nicolau, Joseph L. Kuti, Sean M. Stainton
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
Herein, we present pharmacokinetic and tissue penetration data for oral tedizolid in hospitalized patients with diabetic foot infections (DFI) compared with healthy volunteers. Participants received oral tedizolid phosphate 200 mg every 24 h for 3 do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::842d1b8cf1f59e18d860beb3bcd5ff68
https://doi.org/10.1128/aac.01880-17
https://doi.org/10.1128/aac.01880-17
Publikováno v:
Journal of the American Podiatric Medical Association. 105:381-388
BackgroundVancomycin is a common treatment option for skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Given the increasing prevalence of MRSA, vancomycin is widely used as empirical therapy. In patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f0f17c3c33a9e876eb4d6431b82bd0
https://doi.org/10.7547/14-033
https://doi.org/10.7547/14-033
Autor:
Ashley Shepard, James Nugent, Arlinda Baummer-Carr, Sean M. Stainton, Marguerite L. Monogue, David P. Nicolau, Joseph L. Kuti
Ceftolozane-tazobactam displays potent activity against Gram-negative bacteria that can cause diabetic foot infections (DFI), making it an attractive treatment option when few alternatives exist. The pharmacokinetics and tissue penetration of ceftolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::268a55c72e6ed2e4295afdf25b8b27b6
https://europepmc.org/articles/PMC5700352/
https://europepmc.org/articles/PMC5700352/
Publikováno v:
Antimicrobial Agents and Chemotherapy. 55:4170-4175
Staphylococcus aureus and other Gram-positive organisms, including methicillin-resistant S. aureus , continue to be the predominant pathogens associated with diabetic foot infections. Consequently, linezolid is often used to treat these infections. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297d1de05c36a85a5e55bf9725e7a65c
https://doi.org/10.1128/aac.00445-11
https://doi.org/10.1128/aac.00445-11
Publikováno v:
International Journal of Antimicrobial Agents. 47:247-248
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c124bbd0242829b2bff9aef64da4fb1
https://doi.org/10.1016/j.ijantimicag.2016.01.002
https://doi.org/10.1016/j.ijantimicag.2016.01.002
Autor:
Ashley Shepard, Fiona Rodgers, Angela Kydd, Catherine O’Kane, Anne Fleming, Rhona Galbraith, Craig Williams, Carol Russell, Val Macivor, Teresa Mcintosh, Margaret MacLachlan, William G. Mackay
Publikováno v:
Maturitas. 100:183
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45a850b10d98530022e6739f1db3d728
https://doi.org/10.1016/j.maturitas.2017.03.217
https://doi.org/10.1016/j.maturitas.2017.03.217
Cefazolin, a first-generation cephalosporin with activity against methicillin-susceptible Staphylococcus aureus and streptococci, is often used to treat lower limb infections caused by these pathogens. Antimicrobial penetration is often limited in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3ccb4fe26d07dde2834089adad906d4
https://europepmc.org/articles/PMC3811311/
https://europepmc.org/articles/PMC3811311/